192 related articles for article (PubMed ID: 33939384)
1. Risk Stratification Score Improves Sensitivity for Advanced Colorectal Neoplasia in Colorectal Cancer Screening: The Oshima Study Workgroup.
Sekiguchi M; Kakugawa Y; Ikematsu H; Hotta K; Konda K; Tanaka Y; Takamaru H; Yamada M; Sakamoto T; Saito Y; Imai K; Ito S; Koga Y; Iwasaki M; Murakami Y; Matsuda T
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00319. PubMed ID: 33939384
[TBL] [Abstract][Full Text] [Related]
2. A scoring model for predicting advanced colorectal neoplasia in a screened population of asymptomatic Japanese individuals.
Sekiguchi M; Kakugawa Y; Matsumoto M; Matsuda T
J Gastroenterol; 2018 Oct; 53(10):1109-1119. PubMed ID: 29359244
[TBL] [Abstract][Full Text] [Related]
3. Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test.
He XX; Yuan SY; Li WB; Yang H; Ji W; Wang ZQ; Hao JY; Chen C; Chen WQ; Gao YX; Li LB; Cheng KL; Qian JM; Wang L; Li JN
BMC Gastroenterol; 2019 Dec; 19(1):226. PubMed ID: 31881948
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of serrated lesions, risk factors, and their association with synchronous advanced colorectal neoplasia in asymptomatic screened individuals.
Sekiguchi M; Kakugawa Y; Matsumoto M; Nakamura K; Mizuguchi Y; Takamaru H; Yamada M; Sakamoto T; Saito Y; Matsuda T
J Gastroenterol Hepatol; 2020 Nov; 35(11):1938-1944. PubMed ID: 32441416
[TBL] [Abstract][Full Text] [Related]
5. A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy.
Schroy PC; Wong JB; O'Brien MJ; Chen CA; Griffith JL
Am J Gastroenterol; 2015 Jul; 110(7):1062-71. PubMed ID: 26010311
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
7. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
[TBL] [Abstract][Full Text] [Related]
8. Validity of APCS score as a risk prediction score for advanced colorectal neoplasia in Chinese asymptomatic subjects: A prospective colonoscopy study.
Li W; Zhang L; Hao J; Wu Y; Lu D; Zhao H; Wang Z; Xu T; Yang H; Qian J; Li J
Medicine (Baltimore); 2016 Oct; 95(41):e5123. PubMed ID: 27741134
[TBL] [Abstract][Full Text] [Related]
9. One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).
Wong G; Hope RL; Howard K; Chapman JR; Castells A; Roger SD; Bourke MJ; Macaskill P; Turner R; Williams G; Lim WH; Lok CE; Diekmann F; Cross NB; Sen S; Allen RDM; Chadban SJ; Pollock CA; Tong A; Teixeira-Pinto A; Yang JYH; Williams N; Au EHK; Kieu A; James L; Craig JC
J Am Soc Nephrol; 2019 Jun; 30(6):1061-1072. PubMed ID: 31040191
[TBL] [Abstract][Full Text] [Related]
10. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
[TBL] [Abstract][Full Text] [Related]
11. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
[TBL] [Abstract][Full Text] [Related]
12. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
[TBL] [Abstract][Full Text] [Related]
13. Derivation and validation of a risk scoring model to predict advanced colorectal neoplasm in adults of all ages.
Yang HJ; Choi S; Park SK; Jung YS; Choi KY; Park T; Kim JY; Park DI
J Gastroenterol Hepatol; 2017 Jul; 32(7):1328-1335. PubMed ID: 28012211
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia].
Lu M; Chen HD; Liu CC; Zhang YH; Wei LP; Lyu ZY; Ren JS; Shi JF; Zou SM; Li N; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2104-2111. PubMed ID: 33378824
[No Abstract] [Full Text] [Related]
15. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
16. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
[TBL] [Abstract][Full Text] [Related]
19. Yield of repeat colonoscopy in asymptomatic individuals with a positive fecal immunochemical test and recent colonoscopy.
Kim NH; Jung YS; Lim JW; Park JH; Park DI; Sohn CI
Gastrointest Endosc; 2019 May; 89(5):1037-1043. PubMed ID: 30684602
[TBL] [Abstract][Full Text] [Related]
20. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
